Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sickle Cell Center of Southern Louisiana
Adult and Transitional Sickle Cell Clinicat Tulane Cancer Center
150 South Liberty Street
New Orleans, Louisiana, United States
Email Phone Web
The Tulane University Sickle Cell Center of Southern Louisiana team is comprised of a nurse practitioner and nurse coordinator, a hematologist, a pain management physician and a social worker. With a team that is highly educated in sickle cell care, they can deliver better and more comprehensive care.
The adult sickle cell clinic provides comprehensive care to adults with sickle cell disease. This includes a comprehensive medical exam, laboratory evaluations, psycho-social evaluation and support, and focused education and teaching. Visits are scheduled every 3 to 6 months. The clinic focuses on explaining sickle cell disease and its complications. They focus on recognizing and avoiding future medical problems. Additionally, they provide education about new medical research and treatments in the field.
The pediatric sickle cell clinic is for patients from birth until early adulthood. They provide care in a comprehensive setting that includes a specialized sickle cell nurse and a sickle cell social worker. The focus of this clinic is on sickle cell disease treatment as well as on education and teaching both the patients and their parents.
The Sickle Cell Transitional Program is designed to help adolescents and young adults learn more about managing their sickle cell disease as well as improve their medical care. It consists of a comprehensive sickle cell team that provides special education and psychosocial support for patients as they transition from pediatric to adult care. The sickle cell program is designed for anyone between the ages of 16-25 who is referred by their primary hematologist. They prefer our patients attend this program before they transfer care to an adult program. This will be evaluated on an individual case basis.
Related Content
-
Sandeep Soni, MDSandeep Soni, MD, is the Executive Direc...
-
Charles S. Abrams, MDDr. Abrams is Francis C. Wood Professor ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Sickle cell disease in childrenSickle cell disease (SCD) is an inherite...
-
Brigham and Women’s Sickle Cell Disease ClinicEach person with sickle cell disease is ...
-
Yale New Haven HospitalMedical teams at Yale New Haven Hospital...
-
@juliemakaniScientist|Doctor - Sickle Cell Disease f...
+myBinder